CRO Partnerships
Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control
Brian Healey
IQVIA
PAO-06-26-CL-02Jun 17, 2026
Clinical Evidence
Rethinking Clinical Evidence Requirements in Rare Diseases
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-09Jun 16, 2026
Clinical Trial Needs
Bridging the Gap: Addressing Unmet Needs in Cardiology, Neuroscience, and Respiratory Trials
Bethany Davis, M.D.
Trialmed
PAO-04-26-CL-04May 1, 2026
Clinical Partnership
Quotient Sciences and Biorasi Partner to Accelerate Early Phase Clinical Trials to Patient Proof-of-Concept
Quotient Sciences
PR-04-26-04Apr 1, 2026
Drug Development
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
Quotient Sciences
PR-04-26-03Apr 1, 2026
Patient Communities
Digital Patient and Clinician Platforms are Transforming Clinical Research and Patient Outcomes
Leslie Harrold, M.D.; Michael Atkinson
PPD clinical research business of Thermo Fisher Scientific
PAO-03-26-CL-01Mar 19, 2026
Clinical Recruitment
Breaking Down Barriers in Cardiology Trials to Expand Access to At-Risk Populations
Karen Faulkner, M.D.; Madhu Venkate Gowda, M.D.
Trialmed
PAO-02-26-CL-03Mar 4, 2026
Early-Phase Trials
Innovations in Early-Phase Clinical Trials: Pioneering the Future of Medicine
Craig Boyle. M.D.
Trialmed
PAO-02-26-CL-05Mar 2, 2026
GCP
How Fully Owned, Locally Led Site Networks Deliver Quality, Speed, and Scalability in the Era of ICH E6(R3)
Łukasz Wiech, MD, MBA
Trialmed
PAO-02-26-CL-04Feb 23, 2026
Recruitment
Transforming Effective Patient Recruitment within the Changing Healthcare Landscape
Altair Silva; Sarah Rudolph; Zhe Rachel Angerer
PPD clinical research business of Thermo Fisher Scientific
PAO-01-26-CL-02Jan 22, 2026
Clinical Blinding
Blinding Reconsidered: Why Trial Integrity Depends on More Than a Checkbox
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-09Jan 10, 2026
Recruitment
Minimizing Non-Enrolling Clinical Trial Sites
Stephanie Potter; Priscille Joanno
PPD clinical research business of Thermo Fisher Scientific
PAO-01-26-CL-01Jan 6, 2026
Clinical Support
Accelerating Clinical Trials with Local and Global Support
Alexander Fetkovsky; Roman Hrynchuk
SanaClis
PAO-11-25-CL-05Dec 18, 2025
CRO
Right-Sized CRO Support for Right-Sized Sponsors
Alexander Fetkovsky; Roman Hrynchuk
SanaClis
PAO-10-25-CL-04Nov 6, 2025
Drug Development
Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients
Helix
PR-01-25-NI-28Feb 3, 2025
Clinical CRO
HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
Soligenix, Inc.
PR-01-25-NI-10Jan 14, 2025
Large Molecule
Johnson & Johnson Submits Applications Seeking Approval as Subcutaneous Monotherapy for High-Risk moldering Multiple Myeloma
Johnson & Johnson
PR-10-24-NI-88Nov 8, 2024
Clinical Trials
More Efficient and Cost-Effective Clinical Trials Down Under
Accelagen
PAO-10-24-RTM-11Nov 6, 2024
Cell and Gene Therapy
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Aidan Jones; Erin Schaller
PPD clinical research business of Thermo Fisher Scientific
PAO-06-24-CL-11Jul 9, 2024
Clinical Trials
Optimizing Oncology and Rare Disease Clinical Trials by Focusing on Science and Aligning with both Patients and Investigators
Dave Selkirk
Ergomed
PAO-06-24-CL-09May 30, 2024